Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rauh

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
ACS Chemical Biology|January 24, 2012
A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinaseAndré Koch, Haridas B Rode, André Richters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2024
Reply to Y. Xia et alSebastian Bauer, Jonathan A Fletcher, Daniel Rauh, et al.
Chemmedchem|August 7, 2018
RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer TherapeuticsPatrik Wolle, Jörn Weisner, Marina Keul, et al.
Journal of Medicinal Chemistry|April 9, 2024
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric PromisesKosmas Alexandros Pervanidis, Giovanni Danilo D'Angelo, Jörn Weisner, et al.
ACS Omega|July 3, 2018
Characterization of Covalent-Reversible EGFR InhibitorsSteven Smith, Marina Keul, Julian Engel, et al.
Angewandte Chemie (International Ed. in English)|March 2, 2026
Lipid Pocket Binders Impose Allosteric Changes of Protein Dynamics Around the Active Site of the Protein Kinase p38αSara Medina Gómez, Laurin T Homberg, Mike Bührmann, et al.
Journal of the American Chemical Society|March 6, 2010
Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformationsJeffrey R Simard, Matthäus Getlik, Christian Grütter, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric LigandsJanina Niggenaber, Leonie Heyden, Tobias Grabe, et al.
Journal of Medicinal Chemistry|March 2, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST)Giorgia Mancino, Tom Schulz, Andrea Scrima, et al.
Journal of Chemical Information and Modeling|May 29, 2025
Computational Design of Lysine Targeting Covalent Binders Using RosettaBarr Tivon, Jan Wiese, Matthias P Müller, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
ACS Chemical Biology|January 24, 2012
A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinaseAndré Koch, Haridas B Rode, André Richters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2024
Reply to Y. Xia et alSebastian Bauer, Jonathan A Fletcher, Daniel Rauh, et al.
Chemmedchem|August 7, 2018
RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer TherapeuticsPatrik Wolle, Jörn Weisner, Marina Keul, et al.
Journal of Medicinal Chemistry|April 9, 2024
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric PromisesKosmas Alexandros Pervanidis, Giovanni Danilo D'Angelo, Jörn Weisner, et al.
ACS Omega|July 3, 2018
Characterization of Covalent-Reversible EGFR InhibitorsSteven Smith, Marina Keul, Julian Engel, et al.
Angewandte Chemie (International Ed. in English)|March 2, 2026
Lipid Pocket Binders Impose Allosteric Changes of Protein Dynamics Around the Active Site of the Protein Kinase p38αSara Medina Gómez, Laurin T Homberg, Mike Bührmann, et al.
Journal of the American Chemical Society|March 6, 2010
Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformationsJeffrey R Simard, Matthäus Getlik, Christian Grütter, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric LigandsJanina Niggenaber, Leonie Heyden, Tobias Grabe, et al.
Journal of Medicinal Chemistry|March 2, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST)Giorgia Mancino, Tom Schulz, Andrea Scrima, et al.
Journal of Chemical Information and Modeling|May 29, 2025
Computational Design of Lysine Targeting Covalent Binders Using RosettaBarr Tivon, Jan Wiese, Matthias P Müller, et al.
Pageof 16